東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Vaccine analysis = strategies, princ...

Nunnally, Brian K.

FindBook

Google Book

Amazon

博客來

Vaccine analysis = strategies, principles, and control /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Vaccine analysis/ edited by Brian K. Nunnally, Vincent E. Turula, Robert D. Sitrin.
其他題名:	strategies, principles, and control /
其他作者:	Nunnally, Brian K.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg : : 2015.,
面頁冊數:	xii, 665 p. :ill. (some col.), digital ;24 cm.
內容註:	Live Attenuated Viral Vaccines -- Inactivated Viral Vaccines -- Recombinant Virus Like Particle Protein Vaccines -- Analysis of influenza vaccines -- Live-attenuated and inactivated whole-cell bacterial vaccines -- Analytical control strategy of bacterial subunit vaccines -- Bacterial Polysaccharide Vaccines: Analytical Perspectives -- Glycoconjugate vaccines -- Vaccines in research and development: new production platforms and new biomolecular entities for new needs -- Role of Analytics In Viral Safety -- Deep Sequencing Applications for Vaccine Development and Safety -- Quality-by-design: As related to analytical concepts, control and qualification -- Vaccine Potency Assays -- Establishing a Shelf-life and Setting Lot-release Specifications -- Vaccine Reference Standards -- Lot Release of Vaccines by Regulatory Authorities and Harmonization of Testing Requirements -- Dendritic cell targeting vaccines.
Contained By:	Springer eBooks
標題:	Vaccines - Testing. -
電子資源:	http://dx.doi.org/10.1007/978-3-662-45024-6
ISBN:	9783662450246 (electronic bk.)

Vaccine analysis = strategies, principles, and control /
Vaccine analysisstrategies, principles, and control /[electronic resource] :edited by Brian K. Nunnally, Vincent E. Turula, Robert D. Sitrin. - Berlin, Heidelberg :Springer Berlin Heidelberg :2015. - xii, 665 p. :ill. (some col.), digital ;24 cm.

Live Attenuated Viral Vaccines -- Inactivated Viral Vaccines -- Recombinant Virus Like Particle Protein Vaccines -- Analysis of influenza vaccines -- Live-attenuated and inactivated whole-cell bacterial vaccines -- Analytical control strategy of bacterial subunit vaccines -- Bacterial Polysaccharide Vaccines: Analytical Perspectives -- Glycoconjugate vaccines -- Vaccines in research and development: new production platforms and new biomolecular entities for new needs -- Role of Analytics In Viral Safety -- Deep Sequencing Applications for Vaccine Development and Safety -- Quality-by-design: As related to analytical concepts, control and qualification -- Vaccine Potency Assays -- Establishing a Shelf-life and Setting Lot-release Specifications -- Vaccine Reference Standards -- Lot Release of Vaccines by Regulatory Authorities and Harmonization of Testing Requirements -- Dendritic cell targeting vaccines.

This book is an indispensable tool for anyone involved in the research, development, or manufacture of new or existing vaccines. It describes a wide array of analytical and quality control technologies for the diverse vaccine modalities. Topics covered include the application of both classical and modern bio-analytical tools; procedures to assure safety and control of cross contamination; consistent biological transition of vaccines from the research laboratory to manufacturing scale; whole infectious attenuated organisms, such as live-attenuated and inactivated whole-cell bacterial vaccines and antiviral vaccines using attenuated or inactivated viruses; principles of viral inactivation and the application of these principles to vaccine development; recombinant DNA approaches to produce modern prophylactic vaccines; bacterial subunit, polysaccharide and glycoconjugate vaccines; combination vaccines that contain multiple antigens as well as regulatory requirements and the hurdles of licensure.

ISBN: 9783662450246 (electronic bk.)

Standard No.: 10.1007/978-3-662-45024-6doiSubjects--Topical Terms:

915705
Vaccines
--Testing.

LC Class. No.: QR189 / .V33 2015

Dewey Class. No.: 615.372

Vaccine analysis = strategies, principles, and control /
LDR:02941nmm a2200313 a 4500 001 1993357
003 DE-He213
005 20150630105933.0
006 m d
007 cr nn 008maaau
008 151019s2015 gw s 0 eng d
020 $a 9783662450246 (electronic bk.)
020 $a 9783662450239 (paper)
024 7 $a 10.1007/978-3-662-45024-6 $2 doi
035 $a 978-3-662-45024-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR189 $b .V33 2015
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 615.372 $2 23
090 $a QR189 $b .V116 2015
245 0 0 $a Vaccine analysis $h [electronic resource] : $b strategies, principles, and control / $c edited by Brian K. Nunnally, Vincent E. Turula, Robert D. Sitrin.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a xii, 665 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Live Attenuated Viral Vaccines -- Inactivated Viral Vaccines -- Recombinant Virus Like Particle Protein Vaccines -- Analysis of influenza vaccines -- Live-attenuated and inactivated whole-cell bacterial vaccines -- Analytical control strategy of bacterial subunit vaccines -- Bacterial Polysaccharide Vaccines: Analytical Perspectives -- Glycoconjugate vaccines -- Vaccines in research and development: new production platforms and new biomolecular entities for new needs -- Role of Analytics In Viral Safety -- Deep Sequencing Applications for Vaccine Development and Safety -- Quality-by-design: As related to analytical concepts, control and qualification -- Vaccine Potency Assays -- Establishing a Shelf-life and Setting Lot-release Specifications -- Vaccine Reference Standards -- Lot Release of Vaccines by Regulatory Authorities and Harmonization of Testing Requirements -- Dendritic cell targeting vaccines.
520 $a This book is an indispensable tool for anyone involved in the research, development, or manufacture of new or existing vaccines. It describes a wide array of analytical and quality control technologies for the diverse vaccine modalities. Topics covered include the application of both classical and modern bio-analytical tools; procedures to assure safety and control of cross contamination; consistent biological transition of vaccines from the research laboratory to manufacturing scale; whole infectious attenuated organisms, such as live-attenuated and inactivated whole-cell bacterial vaccines and antiviral vaccines using attenuated or inactivated viruses; principles of viral inactivation and the application of these principles to vaccine development; recombinant DNA approaches to produce modern prophylactic vaccines; bacterial subunit, polysaccharide and glycoconjugate vaccines; combination vaccines that contain multiple antigens as well as regulatory requirements and the hurdles of licensure.
650 0 $a Vaccines $x Testing. $3 915705
650 0 $a Vaccines industry $x Quality control. $3 2131538
650 0 $a Chemistry, Analytic. $3 517805
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Vaccine. $3 1001012
650 2 4 $a Immunology. $3 611031
650 2 4 $a Medical Biochemistry. $3 892387
700 1 $a Nunnally, Brian K. $3 916807
700 1 $a Turula, Vincent E. $3 2131536
700 1 $a Sitrin, Robert D. $3 2131537
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-45024-6
950 $a Biomedical and Life Sciences (Springer-11642)